Yıl: 2021 Cilt: 27 Sayı: 4 Sayfa Aralığı: 249 - 252 Metin Dili: İngilizce DOI: 10.14744/epilepsi.2021.28863 İndeks Tarihi: 17-06-2022

Two Cases of Lafora Disease Diagnosed By Genetical Tests

Öz:
Epilepsy develops related to a complex genetic heredity as many diseases in society. Lafora disease (LD) is an autosomal recessive inheritance. It is localized at EPM2A gen 6q23-25 and encodes tyrosine phosphatase (Laforin protein). About 80% of the patients have mutations in this gene. In a case of LD, rapid and progressive dementia and frequent occipital seizures are clinical symptoms. For definitive diagnosis, through genetical study, EPM2A and EPM2B genes should be analyzed. A male at the age of 18, with a medical history of meningitis and seizures with high temperature. Starting from the age of 10, there have been symptoms such as generalized tonic-clonic (GTC) seizures, startles in the whole body, and forgetfulness. In genetical tests, homozygote deletion of adenine nucleotide in the position of 468 at codon 156 and guanine nucleotide in the position of 469 at codon 157 is found. In other words, there has been dinucleotide deletion which is compatible with LD. A 20-year-old male was examined because of such symptoms as forgetfulness, myoclonia, hallucinations, and GTC clonic seizures. He was diagnosed with LD because of the heterozygote transformation of CCC to CTC at codon 111. Even though genetic disorders have many different reasons, it is advised that every society should have their own advanced studies on gene mutation. In Turkish cases, both of these genes were found mutated, each in different patients through various studies.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, et al. Lafora disease. Epileptic Disord 2016;18(S2):38–62.
  • 2. Singh S, Satishchandra P, Shankar SK, Ganesh S. Lafora disease in the indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Hum Mutat 2008;29(6):E1–12.
  • 3. Sinha S, Satishchandra P, Gayathri N, Yasha TC, Shankar SK. Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India. J Neurol Sci 2007;252(1):16–23.
  • 4. Panzica F, Canafoglia L, Franceschetti S, Binelli S, Ciano C, Visani E, et al. Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clin Neurophysiol 2003;114(6):1041–52.
  • 5. Andrade DM, Ackerley CA, Minett TS, Teive HA, Bohlega S, Scherer SW, et al. Skin biopsy in Lafora disease: Genotype-phenotype correlations and diagnostic pitfalls. Neurology 2003;61(11):1611–4.
  • 6. Ianzano L, Zhang J, Chan EM, Zhao XC, Lohi H, Scherer SW, et al. Lafora progressive myoclonus epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes. Hum Mutat 2005;26(4):397.
  • 7. Ferlazzo E, Trenite DK, de Haan GJ, Nitschke FF, Ahonen S, Gasparini S, et al. Update on pharmacological treatment of progressive myoclonus epilepsies. Curr Pharm Des 2017;23(37):5662– 66.
  • 8. Lohi H, Turnbull J, Zhao XC, Pullenayegum S, Ianzano L, Yahyaoui M, et al. Genetic diagnosis in Lafora disease: Genotype- phenotype correlations and diagnostic pitfalls. Neurology 2007;68(13):996–1001.
APA Bican Demir A, Bora İ (2021). Two Cases of Lafora Disease Diagnosed By Genetical Tests. , 249 - 252. 10.14744/epilepsi.2021.28863
Chicago Bican Demir Aylin,Bora İbrahim Hakkı Two Cases of Lafora Disease Diagnosed By Genetical Tests. (2021): 249 - 252. 10.14744/epilepsi.2021.28863
MLA Bican Demir Aylin,Bora İbrahim Hakkı Two Cases of Lafora Disease Diagnosed By Genetical Tests. , 2021, ss.249 - 252. 10.14744/epilepsi.2021.28863
AMA Bican Demir A,Bora İ Two Cases of Lafora Disease Diagnosed By Genetical Tests. . 2021; 249 - 252. 10.14744/epilepsi.2021.28863
Vancouver Bican Demir A,Bora İ Two Cases of Lafora Disease Diagnosed By Genetical Tests. . 2021; 249 - 252. 10.14744/epilepsi.2021.28863
IEEE Bican Demir A,Bora İ "Two Cases of Lafora Disease Diagnosed By Genetical Tests." , ss.249 - 252, 2021. 10.14744/epilepsi.2021.28863
ISNAD Bican Demir, Aylin - Bora, İbrahim Hakkı. "Two Cases of Lafora Disease Diagnosed By Genetical Tests". (2021), 249-252. https://doi.org/10.14744/epilepsi.2021.28863
APA Bican Demir A, Bora İ (2021). Two Cases of Lafora Disease Diagnosed By Genetical Tests. Epilepsi, 27(4), 249 - 252. 10.14744/epilepsi.2021.28863
Chicago Bican Demir Aylin,Bora İbrahim Hakkı Two Cases of Lafora Disease Diagnosed By Genetical Tests. Epilepsi 27, no.4 (2021): 249 - 252. 10.14744/epilepsi.2021.28863
MLA Bican Demir Aylin,Bora İbrahim Hakkı Two Cases of Lafora Disease Diagnosed By Genetical Tests. Epilepsi, vol.27, no.4, 2021, ss.249 - 252. 10.14744/epilepsi.2021.28863
AMA Bican Demir A,Bora İ Two Cases of Lafora Disease Diagnosed By Genetical Tests. Epilepsi. 2021; 27(4): 249 - 252. 10.14744/epilepsi.2021.28863
Vancouver Bican Demir A,Bora İ Two Cases of Lafora Disease Diagnosed By Genetical Tests. Epilepsi. 2021; 27(4): 249 - 252. 10.14744/epilepsi.2021.28863
IEEE Bican Demir A,Bora İ "Two Cases of Lafora Disease Diagnosed By Genetical Tests." Epilepsi, 27, ss.249 - 252, 2021. 10.14744/epilepsi.2021.28863
ISNAD Bican Demir, Aylin - Bora, İbrahim Hakkı. "Two Cases of Lafora Disease Diagnosed By Genetical Tests". Epilepsi 27/4 (2021), 249-252. https://doi.org/10.14744/epilepsi.2021.28863